Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 232 (RNA5SP232)

Target
RNA5SP232
Molecular classification
Pseudogene, Non-coding RNA pseudogene, rRNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 232 is a member of the rRNA pseudogene family, derived from the 5S ribosomal RNA gene through gene duplication or retrotransposition events[2][6]. Unlike functional 5S rRNA, which plays a key structural role in ribosome assembly and protein synthesis[1][3][5], this pseudogene does not produce functional RNA and is considered genomically inactive. rRNA pseudogenes are generally retained in the genome due to sequence homology but lack the ability to contribute to ribosome structure or mediate cellular functions[2][6]. Some pseudogenes in other families can exert regulatory impacts on gene expression; however, no such role is described for RNA5SP232.\nIf additional details or specifics about function or disease association are needed, experimental confirmation would be required, as no clear evidence supports its activity.

Other names
RN5S232RNA5SP232RNA, 5S ribosomal 232
02

Mechanism of action

Not applicable. There are no drugs targeting RNA5SP232 or other rRNA pseudogenes.

03

Biological functions

No established biological function for RNA5SP232 specifically as it is a pseudogene.However, some pseudogenes have regulatory activities such as chromatin remodeling, sponging of miRNAs and RNA-binding proteins, and mRNA degradation in rare cases.
04

Disease associations

None established for this specific pseudogene.Some pseudogenes have been implicated in cancer and other diseases via modulation of gene expression, but there is no specific evidence for RNA5SP232.
05

Safety considerations

Not applicable; RNA5SP232 is not targeted by drugs and does not raise therapeutic safety concerns.
06

Interacting drugs

None. Pseudogenes are not known to interact with drugs as functional targets.
07

Biomarkers

None known. rRNA pseudogenes are generally not used as biomarkers.

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 232 (RNA5SP232).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 232 (RNA5SP232).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call